SHAILYNSE11 August 2025

Shaily Engineering Plastics Limited has informed the Exchange about Investor Presentation

Shaily Engineering Plastics Limited

SEPL/SE/AUG/25-26 11th August 2025

The General Manager, Corporate Relations/Listing Department BSE Limited Floor 25, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 501423

The Manager, Listing Department National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra – Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: SHAILY

Sub: Q1FY26 - Result Presentation

Ref:

Regulation 30 of the SEBI Listing Regulations, 2015

Dear Sir,

In continuation to our letter dated 06th August 2025, regarding intimation of Earnings Call of the Company scheduled on Monday, 11th August 2025 at 05:00 p.m., to discuss the operational & financial performance of the Company for the quarter ended on 30th June 2025, kindly find enclosed herewith Q1FY26 Result Presentation of the Company.

A copy of the same is also available on our website www.shaily.com.

Thanking You.

Yours truly, For Shaily Engineering Plastics Limited

Harish Punwani Company Secretary & Compliance Officer M. No. A 50950

Encl: a/a

Shaily Engineering Plastics Ltd

Investors Presentation August 2025

Safe Harbor

This presentation and the accompanying slides (the “Presentation”), which have been prepared by Shaily Engineering Plastics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.

This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded.

Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections.

2

Key Performance Highlights

Business Updates for Q1 FY26

Healthcare

19 injection moulding machines are under In response to rising installation in response to customer demand for GLP- customer demand, with 1 drugs completion expected by Q2 FY26

Installation of Plant & Machinery supplied by customer for the manufacture of

Eye Applicators under way

Contract signed for the In response to rising Supply of Pens for customer demand for GLP- 1 drugs GLP-1

Consumer

Order received for mixed material product

Awarded Business for Male Accessories from marquee FMCG customer

4

Key Financial Highlights – Q1FY26 (Consolidated*)

Revenues

Gross Profit Margin

+38%

246.7

179.4

+910 bps

51.2%

42.1%

EBITDA

+95%

70.4

36.1

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

EBITDA Margins

Profit After Tax

+840 bps

28.5%

20.1%

+136%

41.1

Cash PAT#

+91%

52.6

17.4

27.6

(Rs. Cr.)

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

#Cash PAT includes PAT & Depreciation

* Includes the UK & UAE Subsidiary Business

5

Segment Wise Revenue Breakup

Revenue (Consumer)

Revenue (Healthcare)

Revenue (Industrial)

TOTAL REVENUE

14% YoY

151.4

132.8

181% YoY

77.2

19.2

-6% YoY

18.1

38% YoY

246.7

179.4

27.4

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Improved traction in the healthcare segment has been the key driver for the overall growth of the business

On Consolidated Basis

6

Key Financial Highlights – Q1FY26 (Standalone)

Revenues

+33%

225.1

169.0

Gross Profit Margin

+1,140 bps

50.0%

38.6%

EBITDA

+125%

62.7

27.9

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

EBITDA Margins

Profit After Tax

+1,140 bps

27.9%

+268%

36.0

Cash PAT#

+141%

46.6

16.5%

9.8

19.3

(Rs. Cr.)

Q1FY25

Q1FY26

Q1FY25

Q1FY26

Q1FY25

Q1FY26

#Cash PAT includes PAT & Depreciation

7

Operational Trends

n o i t a z i l i t U e n h c a M

i

)

%

(

l

s t n a P s s o r c A

s r e m y l o P f o e m u o V

l

) T M

( d e s s e c o r P

+940 bps

48.7%

39.3%

Q1FY25

Q1FY26

+18.9%

7,016

5,902

Q1FY25

Q1FY26

Revenue Analysis – Domestic vs. Exports

Q1 FY25

vs

Q1 FY26

20.1%

23.9%

79.9%

76.1%

8

Efficient Use of Capital

RoCE

RoE

Fixed Asset Turnover

Total Debt / Equity

+1,610 bps

40.5%

+1,230 bps

30.8%

2.1

0.4

24.4%

18.5%

1.7

0.3

Mar-25

Jun-25

Mar-25

Jun-25

Mar-25

Jun-25

Mar-25

Jun-25

On Consolidated Basis

9

Profit & Loss Statement

Particulars (Rs. Cr.)

Revenue

Raw Material

Employee Expenses

Other Expenses*

Other Income

EBITDA

EBITDA Margin

Depreciation

Finance Cost

PBT

PBT Margin

Tax

PAT

PAT Margin

Cash PAT^

Cash PAT Margin

Consolidated

Standalone

Q1 FY26

Q1 FY25

246.7

120.5

24.9

33.0

2.1

70.4

28.5%

11.4

3.9

55.1

22.3%

14.0

41.1

16.7%

52.6

21.3%

179.4

103.9

17.9

22.2

0.7

36.1

20.1%

10.1

4.4

21.6

12.1%

4.2

17.4

9.7%

27.6

15.4%

YoY %

+38%

+95%

+155%

+136%

+91%

Q1 FY26

Q1 FY25

225.1

112.5

20.6

31.3

2.1

62.7

27.9%

10.6

3.9

48.3

21.4%

12.3

36.0

16.0%

46.6

20.7%

169.0

103.9

17.7

20.9

1.4

27.9

16.5%

9.6

4.4

14.0

8.3%

4.2

9.8

5.8%

19.3

11.4%

YoY %

+33%

+125%

+245%

+268%

+141%

* Other Expenses include Power & Fuel costs

^ Cash PAT = PAT + Depreciation

10

About the Company

Enriching Lives Through Plastics

Shaily Engineering Plastics Limited is India’s largest exporter of plastics components. Established in 1987, the Company provides end-to-end solutions in plastic products and services, whilst delivering superior quality and value to all stakeholders. The Company employs over 2,000+ employees and have over 200+ injection molding machines, with precise, high speed automated and robotic production lines.

Founded in 1987

Revenue* Rs. 787 Crores FY 25

7 Facilities in Gujarat 6 for Plastic 1 for Steel Furniture

Long-standing global relationships with marquee clients

200+ Injection moulding machines

Over 2,000 employees across 7 plants

De-risked Business Model

On Consolidated Basis

11

Business Segments

Consumer

Industrial

Healthcare

✓ Home Furnishings

✓ FMCG Packaging

✓ LED Lights

✓ Toys

✓ Carbon Steel Furniture

✓ Automotive Components

✓ Appliances

✓ High Performance Engineering Components

✓ Platform Devices

✓ Drug Delivery Devices

✓ Pharma Packaging

12

State-of-the-Art Manufacturing Facilities

7 Facilities with over 200 molding machines ranging from 35 tons to 1,000 tons

Rania

Halol

GUJARAT

Rania

❖ Export Oriented Unit ❖ Pharma (Dedicated ISO Class 8 clean

room manufacturing facility)

❖ Others

Halol (GIDC)

❖ Automotive & Engineering

Halol

❖ Carbon Steel ❖ Plastic

Disclaimer: Maps not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness.

13

Board of Directors

Executive Chairman

Mr. Mahendra Sanghvi

Whole Time Director

Ms. Tilottama Sanghvi

Managing Director

Mr. Amit Sanghvi

Executive Director

Mr. Laxman Sanghvi

Independent Director

Dr. Shailesh Ayyangar

Independent Director

Mr. Ranjit Singh

Independent Director

Mr. Samaresh Parida

Independent Director

Mrs. Sangeeta Singh

14

Strong Credit Rating*

LONG TERM BANK FACILITIES

Rs. 238.45 Crs.

CARE A+ ; Outlook: Stable

Rating Action: Upgraded

SHORT TERM BANK FACILITIES

Rs. 35 Crs.

CARE A1

Rating Action: Reaffirmed

Long and established track record in the plastic injection molding business along with experienced Promoters

Growth in Total operating income on the back of increased volumes & higher exports

Sustainable healthy operating margin along with strengthening leverage and debt coverage indicators

New business confirmations from existing clients along with addition of marquee clients across diversified industries

Sustainable healthy operating margin along with strengthening leverage and debt coverage indicators

*Updated as on 31st March 2025

15

Historical Profit & Loss Statement

Particulars (Rs. Cr.)

Revenue

Raw Material

Employee Expenses

Other Expenses*

Other Income

EBITDA

EBITDA Margin

Depreciation

Finance Cost

PBT

PBT Margin

Tax

PAT

PAT Margin

Cash PAT^

Cash PAT Margin

Consolidated

Standalone

FY25

786.8

415.8

80.4

114.5

2.3

178.4

22.7%

42.2

16.9

119.3

15.2%

26.2

93.1

11.8%

135.3

17.2%

FY24

643.9

370.1

57.3

99.5

6.5

123.4

19.2%

35.7

17.9

69.8

10.8%

12.6

57.3

8.9%

93.0

14.4%

FY23

607.1

386.5

47.9

80.8

4.5

96.4

15.9%

33.3

17.9

45.2

7.4%

10.1

35.1

5.8%

68.5

11.3%

FY25

738.1

415.7

72.8

106.0

7.4

151.0

20.5%

39.4

16.9

94.7

12.8%

23.7

70.9

9.6%

110.3

14.9%

FY24

616.0

370.1

55.9

95.2

6.5

101.3

16.4%

34.7

17.9

48.7

7.9%

12.6

36.1

5.9%

70.8

FY23

599.7

386.5

47.2

79.4

4.5

91.1

15.2%

33.2

17.9

40.1

6.7%

10.1

30.0

5.0%

63.2

11.5%

10.5%

* Other Expenses include Power & Fuel costs

^ Cash PAT = PAT + Depreciation

16

Historical Balance Sheet

Particulars Non-Current assets Property, Plant and Equipments Capital Work in Process Intangible assets Investments Intangible assets under development Financial Assets Loans Other Non-Current Assets Income tax assets Total Non-Current Assets Current Assets Inventories Financial Assets Trade Receivables Cash and Cash Equivalents Loans Other Current Assets Current tax assets (Net) Total Current Assets Total Assets

Mar-25

Mar-24

Mar-23

459.1 17.4 42.1 - 0.3

0.5 23.9 3.8 547.0

435.4 15.3 38.0 0.0 5.1

0.5 18.3 2.7 515.3

347.9 49.0 19.0 0.0 19.3

0.5 17.2 2.1 455.0

137.8

83.6

73.0

171.7 23.1 0.3 52.6 - 385.6 932.6

117.4 26.4 6.4 33.5 0.0 267.2 782.5

91.9 23.0 5.7 44.1 0.0 237.7 692.7

Particulars Equity Equity Share Capital Other Equity

Total Equity Non-Current Liabilities Financial Liabilities Long-term borrowings Deferred tax liabilities (net) Other long-term liabilities Long-term provisions

Total Non-Current Liabilities Current Liabilities Short-term borrowings Trade payables Other financial liabilities Other current liabilities Short-term provisions Current tax liabilities (net) Total Current Liabilities

Total Equity and Liabilities

Mar-25

Mar-24

Mar-23

9.2 538.5

547.7

40.1 23.6 0.2 3.9

67.8

147.6 99.0 12.5 44.0 7.1 6.9 317.1

932.6

9.2 450.0

459.2

69.8 20.8 1.2 2.2

94.1

138.5 68.7 10.3 10.4 1.3 0.0 229.2

782.5

9.2 392.2

401.4

62.5 17.0 1.2 2.3

83.1

124.3 53.4 9.3 20.0 1.2 0.0 208.2

692.7

On Consolidated basis

17

Historical Balance Sheet

Particulars Non-Current assets Property, Plant and Equipments Capital Work in Process Intangible assets Investments Intangible assets under development Financial Assets Loans Other Non-Current Assets Income tax assets Total Non-Current Assets Current Assets Inventories Financial Assets Trade Receivables Cash and Cash Equivalents Loans Other Current Assets Current tax assets (Net) Total Current Assets Total Assets

Mar-25

Mar-24

Mar-23

457.6 17.4 19.5 11.3 0.3

0.5 23.9 1.5 532.0

434.9 15.3 17.8 20.6 2.1

0.5 18.3 2.3 511.8

348.6 49.0 13.8 15.4 5.7

0.5 17.2 2.1 452.3

137.8

83.6

73.0

148.1 8.5 0.3 44.0 - 338.7 870.6

111.7 8.6 6.4 29.9 0.0 240.3 752.1

88.8 17.7 13.7 39.2 0.0 232.4 684.6

Particulars Equity Equity Share Capital Other Equity

Total Equity Non-Current Liabilities Financial Liabilities Long-term borrowings Deferred tax liabilities (net) Other long-term liabilities Long-term provisions

Total Non-Current Liabilities Current Liabilities Short-term borrowings Trade payables Other financial liabilities Other current liabilities Short-term provisions Current tax liabilities (net) Total Current Liabilities

Total Equity and Liabilities

Mar-25

Mar-24

Mar-23

9.2 487.0

496.2

40.1 22.6 0.2 3.9

66.8

147.6 97.9 12.5 38.0 7.1 4.4 307.6

870.6

9.2 422.3

431.5

69.8 20.4 1.2 2.2

93.6

138.5 67.2 10.3 9.7 1.3 0.0 227.0

752.1

9.2 386.5

395.6

62.5 16.9 1.2 2.3

82.9

123.2 51.7 10.4 19.5 1.2 0.0 206.1

684.6

On Standalone basis

18

Cash Flow Statement

Consolidated

Standalone

Particulars (Rs. Cr.)

Profit Before Tax

Adjustments

Operating profit before working capital changes

Changes in working capital

Cash generated from operations

Direct taxes paid (net of refund)

Net Cash from Operating Activities

Net Cash from Investing Activities

Net Cash from Financing Activities

Net Change in cash and cash equivalents

Add: Cash & Cash equivalents at the beginning of the period

Closing Cash Balance

FY25

119.3

56.6

175.9

-48.3

127.6

-17.5

110.1

-71.3

-41.9

-3.1

22.2

19.1

FY24

69.8

58.2

128.0

-27.0

101.0

-8.8

92.3

-99.0

9.8

3.1

19.1

22.2

FY23

45.2

51.4

96.6

-0.6

96.0

-6.0

90.0

-100.9

-5.1

-16.0

35.1

19.1

FY25

94.7

46.6

141.3

-30.5

110.7

-15.1

95.6

-53.7

-41.9

0.0

4.4

4.4

FY24

48.7

56.2

104.8

-21.6

83.3

-8.8

74.5

-92.4

4.6

-13.3

17.7

4.4

FY23

40.1

50.4

90.5

0.2

90.7

-6.0

84.7

-93.3

-5.1

-13.7

31.4

17.7

19

Contact

Company :

Investor Relations Advisors :

Shaily Engineering Plastics Ltd. CIN – L51900GJ1980PLC065554

Mr. Sanjay Shah, Chief Strategy Officer sanjay@shaily.com

www.shaily.com

Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285

Mr. Shogun Jain / Mr. Deven Dhruva shogun.jain@sgapl.net / deven.dhruva@sgapl.net +91 77383 77756 / +91 98333 73300 www.sgapl.net

20

← All TranscriptsSHAILY Stock Page →